Healthcare & Life Sciences
AEON Biopharma
United Statesaeonbiopharma.com
AEON Biopharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About AEON Biopharma
AEON Biopharma is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
AEON Biopharma develops ABP-450 (prabotulinumtoxinA), a branded biosimilar therapeutic botulinum toxin intended to provide a lower-cost alternative to Botox for treating neuromuscular conditions.
Explore AEON Biopharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.